BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 20009927)

  • 1. Multimodality management of non-small cell lung cancer patients with brain metastases.
    Ricciardi S; de Marinis F
    Curr Opin Oncol; 2010 Mar; 22(2):86-93. PubMed ID: 20009927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of brain metastases from lung cancer: chemotherapy.
    Schuette W
    Lung Cancer; 2004 Aug; 45 Suppl 2():S253-7. PubMed ID: 15552807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastases in lung cancer.
    Gaspar LE
    Expert Rev Anticancer Ther; 2004 Apr; 4(2):259-70. PubMed ID: 15056056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidisciplinary management of brain metastases.
    Eichler AF; Loeffler JS
    Oncologist; 2007 Jul; 12(7):884-98. PubMed ID: 17673619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment for brain metastases of lung cancer].
    Ueoka H
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():426-31. PubMed ID: 9369918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
    Suh JH; Stea B; Nabid A; Kresl JJ; Fortin A; Mercier JP; Senzer N; Chang EL; Boyd AP; Cagnoni PJ; Shaw E
    J Clin Oncol; 2006 Jan; 24(1):106-14. PubMed ID: 16314619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
    Carolan H; Sun AY; Bezjak A; Yi QL; Payne D; Kane G; Waldron J; Leighl N; Feld R; Burkes R; Keshavjee S; Shepherd F
    Lung Cancer; 2005 Jul; 49(1):109-15. PubMed ID: 15949596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapy.
    Zabel A; Debus J
    Lung Cancer; 2004 Aug; 45 Suppl 2():S247-52. PubMed ID: 15552806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of brain metastases.
    Soffietti R; Rudā R; Mutani R
    J Neurol; 2002 Oct; 249(10):1357-69. PubMed ID: 12382150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases of breast cancer.
    Melisko ME; Kunwar S; Prados M; Berger MS; Park JW
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):253-68. PubMed ID: 15877523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of prophylactic cranial irradiation in regionally advanced non-small cell lung cancer. A Southwest Oncology Group Study.
    Rusch VW; Griffin BR; Livingston RB
    J Thorac Cardiovasc Surg; 1989 Oct; 98(4):535-9. PubMed ID: 2552227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-brain radiotherapy in the management of brain metastasis.
    Khuntia D; Brown P; Li J; Mehta MP
    J Clin Oncol; 2006 Mar; 24(8):1295-304. PubMed ID: 16525185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.
    Pronzato P; Bruna F; Neri E; Roveri D; Trabucchi A; Vanoli M; Vigani A; Vaira F; Losardo P; Bertelli G
    Anticancer Res; 1995; 15(2):517-9. PubMed ID: 7539236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
    Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality therapy of lung cancer.
    Livingston RB
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
    Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
    Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy for brain metastases: improving the therapeutic ratio.
    Patel RR; Mehta MP
    Clin Cancer Res; 2007 Mar; 13(6):1675-83. PubMed ID: 17363520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain metastases: current management and new developments.
    Soffietti R; Rudà R; Trevisan E
    Curr Opin Oncol; 2008 Nov; 20(6):676-84. PubMed ID: 18841050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motexafin gadolinium: a clinical review of a novel radioenhancer for brain tumors.
    Khuntia D; Mehta M
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):981-9. PubMed ID: 15606327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.